Search Results - "Mochon, Leticia García"

Refine Results
  1. 1
  2. 2

    A Procedure for Deriving Formulas to Convert Transition Rates to Probabilities for Multistate Markov Models by Jones, Edmund, Epstein, David, García-Mochón, Leticia

    Published in Medical decision making (01-10-2017)
    “…For health-economic analyses that use multistate Markov models, it is often necessary to convert from transition rates to transition probabilities, and for…”
    Get full text
    Journal Article
  3. 3

    The economic value of time of informal care and its determinants (The CUIDARSE Study) by Oliva-Moreno, Juan, Peña-Longobardo, Luz María, García-Mochón, Leticia, Del Río Lozano, María, Mosquera Metcalfe, Isabel, García-Calvente, María Del Mar

    Published in PloS one (21-05-2019)
    “…The main aims of this paper are to analyse the monetary value of informal care time using different techniques and to identify significant variables associated…”
    Get full text
    Journal Article
  4. 4

    Cost transferability problems in economic evaluation as a framework for an European health care and social costs database by García-Mochón, Leticia, Rovira Forns, Joan, Espin, Jaime

    Published in Cost effectiveness and resource allocation (18-07-2021)
    “…This article presents part of the work within Work Package 3 (WP3) of Impact HTA (Improved methods and actionable tools for enhancing HTA), a H2020 EU-funded…”
    Get full text
    Journal Article
  5. 5

    Optimal start in dialysis shows increased survival in patients with chronic kidney disease by Caro Martínez, Araceli, Olry de Labry Lima, Antonio, Muñoz Terol, José Manuel, Mendoza García, Óscar Javier, Remón Rodríguez, César, García Mochón, Leticia, Castro de la Nuez, Pablo, Aresté Fosalba, Nuria

    Published in PloS one (30-07-2019)
    “…To compare the survival among patients with chronic kidney disease who had optimal starts of renal replacement therapy, dialysis or hemodialysis, with patients…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs by Espín, Jaime, Špacírová, Zuzana, Rovira, Joan, Epstein, David, Olry de Labry Lima, Antonio, García-Mochón, Leticia

    Published in BMC health services research (27-03-2022)
    “…Costs are one of the critical factors for the transferability of the results in health technology assessment and economic evaluation. The objective is to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Mapping capacity to conduct health technology assessment in Central, Eastern and South-Eastern Europe by de Labry Lima, Antonio Olry, Mochon, Leticia García, Martínez, Araceli Caro, Ruiz, Eva Martín, Balbino, Jaime Espin

    Published in Croatian medical journal (01-02-2016)
    “…To provide insights into the capacity to conduct health technology assessment (HTA) in Central, Eastern, and South-Eastern Europe (CESEE), taking account of…”
    Get full text
    Journal Article Paper
  10. 10

    Determinants of the willingness to pay and willingness to accept in the valuation of informal care. The CUIDARSE study by Oliva, Juan, Peña Longobardo, Luz María, García-Mochón, Leticia, Abellán-Perpìñan, José María, García-Calvente, María del Mar

    Published in Applied economic analysis (10-11-2023)
    “…Purpose – This paper aims to study the value of informal care (IC) time from the perspective of caregivers using two alternative contingent valuation tools –…”
    Get full text
    Journal Article
  11. 11

    Cost-effectiveness of a primary care-based exercise intervention in perimenopausal women. The FLAMENCO Project by Špacírová, Zuzana, Epstein, David, García-Mochón, Leticia, Aparicio, Virginia A., Borges-Cosic, Milkana, López del Amo, M. Puerto, Martín-Martín, José J.

    Published in Gaceta sanitaria (01-11-2019)
    “…Adequate physical activity levels and a healthy lifestyle may prevent all kinds of non-communicable diseases, promote well-being and reduce health-care costs…”
    Get full text
    Journal Article
  12. 12

    Adoption of the HPV vaccine: a case study of three emerging countries by Caro Martínez, Araceli, Espín Balbino, Jaime, Lemgruber, Alexandre, Martín Ruiz, Eva, Olry de Labry Lima, Antonio, García-Mochón, Leticia, Lessa, Fernanda

    “…The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries, due to its potential to reduce the impact of…”
    Get full text
    Journal Article
  13. 13

    Costing methodologies in European economic evaluation guidelines: commonalities and divergences by García-Mochón, Leticia, Špacírová, Zuzana, Espín, Jaime

    Published in The European journal of health economics (01-08-2022)
    “…From both the methodological point of view and standardization of methodology, little attention has been paid to the estimation of direct costs in evaluation…”
    Get full text
    Journal Article
  14. 14

    A general framework for classifying costing methods for economic evaluation of health care by Špacírová, Zuzana, Epstein, David, García-Mochón, Leticia, Rovira, Joan, de Labry Lima, Antonio Olry, Espín, Jaime

    Published in The European journal of health economics (01-06-2020)
    “…According to the most traditional economic evaluation manuals, all "relevant" costs should be included in the economic analysis, taking into account factors…”
    Get full text
    Journal Article
  15. 15

    A comparison of the accuracy of liquid cytology versus conventional screening: a meta-analysis of split-sample studies by Epstein, David, de Labry Lima, Antonio Olry, Mochón, Leticia García, Balbino, Jaime Espín, Esquivias, Javier

    “…The aim of the paper is to compare the accuracy and effectiveness of liquid-based versus conventional cytology when used as part of a process of population…”
    Get full text
    Journal Article
  16. 16

    Challenges for Economic Evaluations of Advanced Therapy Medicinal Products: A Systematic Review by Olry de Labry-Lima, Antonio, Ponce-Polo, Angela, García-Mochón, Leticia, Ortega-Ortega, Marta, Pérez-Troncoso, Daniel, Epstein, David

    Published in Value in health (01-01-2023)
    “…Advanced therapy medicinal products (ATMPs) are drugs for human use for the treatment of chronic, degenerative, or life-threatening diseases that are based on…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20